Diagnoses treated, medications tried and failed, and patient's response to itch or burning sensations following nemolizumab

Summary of patient demographics, diagnoses associated with pruritus, duration of skin
disease, topical medication, phototherapy treatment, oral antihistamine, oral neuropathic agents,
oral antibiotics, systemic anti-inflammatory therapy, number and dosage of nemolizumab
received, clinical itch or burning response reported as both percentage improvement and NRS
(Peak Pruritus or Burning Numerical Rating Sale), and adverse reactions are reported.